Reply to: Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy"

被引：0
|
作者：
Koemans, W. J. [1 ]
van Sandick, J. W. [1 ]
Huitema, A. D. R. [2 ,3 ]
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pharm, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[3] Univ Med Ctr Utrecht, Dept Clin Pharm 3, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
来源：
EJSO | 2020年 / 46卷 / 12期
关键词：
D O I：
10.1016/j.ejso.2020.09.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2343 / 2343
页数：1
相关论文
共 50 条
  • [41] Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix:: Preliminary results of a survival analysis
    Marcotte, Eric
    Sideris, Lucas
    Drolet, Pierre
    Mitchell, Andrew
    Frenette, Suzanne
    Leblanc, Guy
    Leclerc, Yves E.
    Dube, Pierre
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (10) : 2701 - 2708
  • [42] Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinosis - In reply
    Verwaal, VJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) : 1529 - 1529
  • [43] Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin for Peritoneal Carcinomatosis Arising from Appendix: Preliminary Results of a Survival Analysis
    Eric Marcotte
    Lucas Sideris
    Pierre Drolet
    Andrew Mitchell
    Suzanne Frenette
    Guy Leblanc
    Yves E. Leclerc
    Pierre Dubé
    Annals of Surgical Oncology, 2008, 15 : 2701 - 2708
  • [44] Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis
    Masckauchan, Daiana
    Trabulsi, Nora
    Dube, Pierre
    Aube-Lecompte, Marie-Eve
    Cloutier, Alexis-Simon
    Mitchell, Andrew
    Sideris, Lucas
    SURGICAL ONCOLOGY-OXFORD, 2019, 28 : 69 - 75
  • [45] Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin for Peritoneal Carcinomatosis Arising From Colorectal Cancer
    Gervais, Mai-Kim
    Dube, Pierre
    McConnell, Yarrow
    Drolet, Pierre
    Mitchell, Andrew
    Sideris, Lucas
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (07) : 438 - 443
  • [46] Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin
    de Bree, E
    Romanos, J
    Michalakis, J
    Relakis, K
    Georgoulias, V
    Melissas, J
    Tsiftsis, DD
    ANTICANCER RESEARCH, 2003, 23 (3C) : 3019 - 3027
  • [47] Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
    Verwaal, VJ
    van Ruth, S
    de Bree, E
    van Slooten, GW
    van Tinteren, H
    Boot, H
    Zoetmulder, FAN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) : 3737 - 3743
  • [48] Risk factors for peritoneal carcinomatosis in gastric cancer patients, and outcomes following resection and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Kim, Ki Won
    Chow, Oliver
    Parikh, Kunal
    Blank, Sima
    Jibara, Ghalib
    Labow, Daniel M.
    Hiotis, Spiros P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis arising from gastric cancer
    Piso, P.
    Glockzin, G.
    Schlitt, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [50] Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
    Yu, Hsin-Hsien
    Yonemura, Yutaka
    Ng, Hui-Ji
    Lee, Ming-Che
    Su, Bor-Chyuan
    Hsieh, Mao-Chih
    CANCERS, 2023, 15 (13)
12345